Literature DB >> 11493682

Ubiquitination and degradation of Syk and ZAP-70 protein tyrosine kinases in human NK cells upon CD16 engagement.

R Paolini1, R Molfetta, M Piccoli, L Frati, A Santoni.   

Abstract

Syk and ZAP-70 nonreceptor protein tyrosine kinases (PTKs) are essential elements in several cascades coupling immune receptors to intracellular responses. The critical role of these kinases in promoting the propagation of intracellular signaling requires a tight regulation of their activity, thus the existence of a negative feedback loop regulating their expression can be hypothesized. Herein, we have investigated whether ubiquitin-dependent proteolysis could be a mechanism responsible for controlling the fate of Syk and ZAP-70 after their immunoreceptor-induced activation. We found that both Syk and ZAP-70 become ubiquitinated in response to aggregation of the low affinity Fc receptor for IgG (CD16) on human natural killer cells. We confirmed the identity of the major in vivo ubiquitinated kinase species by performing an in vitro ubiquitination assay. In addition, we found that after CD16 stimulation, ubiquitinated forms of Syk and ZAP-70 associate with the receptor complex. After CD16 engagement, we also observed a decrease in the stability of Syk and ZAP-70 PTKs that is counteracted by pretreatment with either proteasome or lysosomal inhibitors. Moreover, in the presence of the proteasome inhibitor, epoxomicin, we observed an accumulation of ubiquitinated forms of both kinases. Our findings provide evidence of ligand-induced ubiquitination of nonreceptor PTKs belonging to the Syk family and propose the ubiquitin-dependent proteasome-mediated degradation pathway as a mechanism for attenuating the propagation of intracellular signaling initiated by immune receptor engagement.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11493682      PMCID: PMC55500          DOI: 10.1073/pnas.161298098

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

1.  Ubiquitin-mediated degradation of active Src tyrosine kinase.

Authors:  K F Harris; I Shoji; E M Cooper; S Kumar; H Oda; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

2.  The linker phosphorylation site Tyr292 mediates the negative regulatory effect of Cbl on ZAP-70 in T cells.

Authors:  N Rao; M L Lupher; S Ota; K A Reedquist; B J Druker; H Band
Journal:  J Immunol       Date:  2000-05-01       Impact factor: 5.422

3.  Recognition of the polyubiquitin proteolytic signal.

Authors:  J S Thrower; L Hoffman; M Rechsteiner; C M Pickart
Journal:  EMBO J       Date:  2000-01-04       Impact factor: 11.598

Review 4.  BLNK: connecting Syk and Btk to calcium signals.

Authors:  T Kurosaki; S Tsukada
Journal:  Immunity       Date:  2000-01       Impact factor: 31.745

5.  Monoubiquitin carries a novel internalization signal that is appended to activated receptors.

Authors:  S C Shih; K E Sloper-Mould; L Hicke
Journal:  EMBO J       Date:  2000-01-17       Impact factor: 11.598

6.  Tyrosine kinase-dependent ubiquitination of CD16 zeta subunit in human NK cells following receptor engagement.

Authors:  R Paolini; A Serra; R Molfetta; M Piccoli; L Frati; A Santoni
Journal:  Eur J Immunol       Date:  1999-10       Impact factor: 5.532

7.  Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines.

Authors:  B Perussia; C Ramoni; I Anegon; M C Cuturi; J Faust; G Trinchieri
Journal:  Nat Immun Cell Growth Regul       Date:  1987

8.  Antigen receptor tail clue.

Authors:  M Reth
Journal:  Nature       Date:  1989-03-30       Impact factor: 49.962

9.  Latent membrane protein 2A of Epstein-Barr virus binds WW domain E3 protein-ubiquitin ligases that ubiquitinate B-cell tyrosine kinases.

Authors:  G Winberg; L Matskova; F Chen; P Plant; D Rotin; G Gish; R Ingham; I Ernberg; T Pawson
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

Review 10.  Tyrosine kinase SYK: essential functions for immunoreceptor signalling.

Authors:  M Turner; E Schweighoffer; F Colucci; J P Di Santo; V L Tybulewicz
Journal:  Immunol Today       Date:  2000-03
View more
  23 in total

1.  The non-receptor tyrosine kinase Syk is a target of Cbl-mediated ubiquitylation upon B-cell receptor stimulation.

Authors:  N Rao; A K Ghosh; S Ota; P Zhou; A L Reddi; K Hakezi; B K Druker; J Wu; H Band
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

2.  β2 integrin induces TCRζ-Syk-phospholipase C-γ phosphorylation and paxillin-dependent granule polarization in human NK cells.

Authors:  Michael E March; Eric O Long
Journal:  J Immunol       Date:  2011-01-26       Impact factor: 5.422

3.  K33-linked polyubiquitination of Zap70 by Nrdp1 controls CD8(+) T cell activation.

Authors:  Mingjin Yang; Taoyong Chen; Xuelian Li; Zhou Yu; Songqing Tang; Chen Wang; Yan Gu; Yanfang Liu; Sheng Xu; Weihua Li; Xuemin Zhang; Jianli Wang; Xuetao Cao
Journal:  Nat Immunol       Date:  2015-09-21       Impact factor: 25.606

Review 4.  Strategies to enhance NK cell function for the treatment of tumors and infections.

Authors:  Jacquelyn Freund-Brown; Leilani Chirino; Taku Kambayashi
Journal:  Crit Rev Immunol       Date:  2018       Impact factor: 2.214

Review 5.  Up on the tightrope: natural killer cell activation and inhibition.

Authors:  Lewis L Lanier
Journal:  Nat Immunol       Date:  2008-05       Impact factor: 25.606

6.  Fgr but not Syk tyrosine kinase is a target for beta 2 integrin-induced c-Cbl-mediated ubiquitination in adherent human neutrophils.

Authors:  Fredrik Melander; Tommy Andersson; Karim Dib
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

7.  Human NK Cells Downregulate Zap70 and Syk in Response to Prolonged Activation or DNA Damage.

Authors:  Jason L Pugh; Neda Nemat-Gorgani; Paul J Norman; Lisbeth A Guethlein; Peter Parham
Journal:  J Immunol       Date:  2017-12-20       Impact factor: 5.422

8.  Rapid ubiquitination of Syk following GPVI activation in platelets.

Authors:  Carol A Dangelmaier; Patricia G Quinter; Jianguo Jin; Alexander Y Tsygankov; Satya P Kunapuli; James L Daniel
Journal:  Blood       Date:  2005-02-08       Impact factor: 22.113

9.  Evaluation of the Functional Capacity of NK Cells of Melanoma Patients in an In Vitro Model of NK Cell Contact with K562 and FemX Tumor Cell Lines.

Authors:  Gordana Konjevic; Ana Vuletic; Katarina Mirjacic Martinovic; Ana Krivokuca; Radmila Jankovic; Nada Babovic
Journal:  J Membr Biol       Date:  2017-09-08       Impact factor: 1.843

10.  Type III effector AvrPtoB requires intrinsic E3 ubiquitin ligase activity to suppress plant cell death and immunity.

Authors:  Robert B Abramovitch; Radmila Janjusevic; C Erec Stebbins; Gregory B Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.